A Study of ZT002 Injection in Adult Chinese Subjects With Type 2 Diabetes Mellitus (T2DM)

Clinical trial NCT07065032 · COMPLETED

Trial details

NCT number: NCT07065032
Sponsor: Beijing QL Biopharmaceutical Co.,Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-02-19
Primary completion: 2024-07-22
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.